Innovation has always been the lifeblood of the pharmaceutical industry and while new active ingredients are of vital importance, improvements in drug delivery and drug targeting systems, in both device and dosage form, provide many more opportunities for enhancing efficacy, improving the patient experience and achieving commercial differentiation.
However, working with new dosage forms can present numerous challenges for R&D, production and quality control.